✦ LIBER ✦

L-hyoscyamine is a reasonable cost-effective alternative to glucagon in patients undergoing ERCP

✍ Scribed by SL Lahoti; M.F. Catalano; WJ Hogan; JE Geenen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective, double-blind trial of L-h

✍ MF Catalano; J Geenen; A Bohorfoush; M Schmalz; GK Johnson; W Hogan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Acute normovolemic hemodilution is a cos

✍ T. G. Monk; L. T. Goodnough; J. D. Birkmeyer; M. E. Brecher; W. J. Catalona 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 689 KB

M1224 Routine Duodenal Biopsy Is a Cost-

✍ Simring, Alexander A.; Eslick, Guy D.; Kalantar, Jamshid S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Restricting HFE genotyping to patients w

✍ S. Moodie; L. Ang; G.E. Levin; J. Stenner; V. Murday; J.D. Maxwell 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 141 KB

PCV101 IS PRASUGREL COST-EFFECTIVE RELAT

✍ A Davies; M Sculpher; C Schmitt; A Barrett; J Clouth; McCollam PL; A Bakhai 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB